GraMedica Announces Opening of European Union (EU) Office

GraMedica Announces Opening of European Union (EU) Office
Michigan based foot care solutions company establishes European headquarters in Poland.

Press Release ( - MACOMB, Mich. - Feb 16, 2018 - The mission of “Changing lives, one foot at a time” has expanded globally with Michigan-based GraMedica’s opening of a permanent EU Office. Increasing awareness of the importance of foot heath and alignment Worldwide is the focus of this expansion. The EU office serves increasing demand for GraMedica foot care solutions by European orthopedic and podiatric surgeons- primarily the flagship HyProCure®line.  A patented titanium stent that instantly corrects certain hindfoot disorders that are well known to cause back pain and otherwise compromise quality of life. The minimally invasive  HyProCure® is used in both children and adults.

Poland was chosen due to it’s central location and desirability as an emerging EU country. This follows GraMedica opening an Asian headquarters in Shanghai last year.

About GraMedica

GraMedica is a global medical device company that’s passionate about creating innovative foot and ankle products that improve patient options and outcomes. We educate dfpup foot and ankle surgeons in over 70 countries. We are committed to helping create ongoing improvement in the quality of healthcare for both patients and physicians through premier product lines including the Soleus Foot Care Collection, opti-toe® digital implant, HyProCure® sinus tarsi stent, and osteo-WEDGE® locking plate system. To learn more about GraMedica, please visit our website at

Source : GraMedica

You may also like this  



Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.